文献速递神经肿瘤

5-氨基乙酰丙酸与术中低场磁共振联合用于高级别胶质瘤手术

Combined Use of 5-Aminolevulinic Acid and Intraoperative Low-Field Magnetic Resonance Imaging in High-Grade Glioma Surgery.
PubMed 文献 · World Neurosurg · 2019-06-14

该回顾性研究纳入2013年1月至2018年1月接受大体全切除的高级别胶质瘤患者118例,比较单独使用5-氨基乙酰丙酸(5-ALA)、单独使用术中低场磁共振(iMRI)及两者联合三组的切除程度与临床结局;结果显示三组在切除程度≥90%、并发症、新发永久性神经功能缺损等方面均无统计学显著差异。

要点

  • 联合使用5-ALA与iMRI并未在切除程度、并发症等指标上优于单独使用。
  • 三组切除程度≥90%的比例分别为73%、73.7%和71.8%,差异无统计学意义。
  • 单独使用iMRI似乎有略优的趋势,但未达统计学显著。

核心结论

  • 联合使用iMRI与5-ALA与单独使用这两种技术相比,并未改善所研究的变量。
  • 单独使用iMRI观察到略优效果的趋势。

研究设计与样本

  • 回顾性纳入2013年1月至2018年1月符合大体全切除条件的高级别胶质瘤患者。
  • 共118例手术,按5-ALA引导(5A组)、iMRI(iMRI组)或两者联合(5A-iMRI组)分组。

主要发现

  • 切除程度≥90%:5A组73%,iMRI组73.7%,5A-iMRI组71.8%,P=0.94。
  • 并发症率:5A组18.3%,iMRI组5.3%,5A-iMRI组7.7%,P=0.17。
  • 术后1个月新发或原有神经功能缺损加重:5A组13.3%,iMRI组10.5%,5A-iMRI组15.4%,P=0.26。
  • 平均住院天数:5A组9.5天,iMRI组6.4天,5A-iMRI组7.6天,P=0.18。
  • 手术时间:5A组212.4分钟,iMRI组187.9分钟,5A-iMRI组201.4分钟,P=0.13。

临床怎么用

  • 对于高级别胶质瘤的大体全切除手术,联合使用5-ALA与iMRI未显示额外获益,临床可根据实际情况选择单独或联合使用。

局限性

  • 本研究为回顾性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to assess the impact of 5-aminolevulinic acid (5-ALA) and low-field intraoperative magnetic resonance imaging (iMRI) on the extent of resection of high-grade gliomas (HGGs). Results are compared with those obtained when using 5-ALA and iMRI separately. METHODS: We retrospectively included patients with an HGG eligible for gross total resection (GTR) from January 2013 to January 2018. Patients were included according to 5-ALA surgical guidance (5A-group), iMRI (iMRI-group), or both (5A-iMRI-group). Surgical variables were registered, and presurgical and postsurgical radiologic and clinical variables were analyzed. Extent of resection ≥90%, complications, and new permanent neurologic deficit were compared using the chi-squared and analysis of variance tests. Other variables studied were mortality, average hospital stay, surgical time, and Karnofsky Performance Scale status before and after surgery. RESULTS: Most of the 118 procedures carried out were in men (59.2%). The mean age was 58 years. Sixty patients (50.8%) were operated on using exclusively 5-ALA assistance (5A-group), 19 (16.1%) using iMRI (iMRI-group), and 39 (33%) combining both techniques (5A-IMRI-group). There were no statistically significant differences among 3 groups regarding extent of resection ≥90% (73% 5A, 73.7% iMRI, 71.8% 5A-iMRI, P = 0.94); complication rates (18.3% 5A, 5.3% iMRI, 7.7% 5A-iMRI, P = 0.17); new or worsening of preexisting neurologic deficit at 1-month follow-up (13.3% 5A, 10.5% iMRI, 15.4% 5A-iMRI, P = 0.26); average hospital stay in days (9.5 5A, 6.4 iMRI, 7.6 5A-iMRI, P = 0.18); Karnofsky Performance Scale; nor surgical time in minutes (212.4 5A, 187.9 iMRI, 201.4 5A-iMRI, P = 0.13). CONCLUSIONS: In our experience, combined use of iMRI and 5-ALA does not improve the studied variables when compared with those technologies when used separately, even though a slight tendency of a superior effectiveness is observed when using iMRI individually.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bassaganyas-Vancells C, Roldán P, González JJ, et al. Combined Use of 5-Aminolevulinic Acid and Intraoperative Low-Field Magnetic Resonance Imaging in High-Grade Glioma Surgery. World Neurosurg. 2019. PMID: 31203073. doi:10.1016/j.wneu.2019.06.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。